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Purmorphamine Induces Osteogenesis by Activation
of the Hedgehog Signaling Pathway
osteogenesis in mouse mesenchymal progenitor cells
(C3H10T1/2). C3H10T1/2 cells are multipotent mesen-
chymal progenitor cells that have the potential to dif-
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10550 North Torrey Pines Road system to study the differentiation of osteoblasts. Purmor-
phamine induces alkaline phosphatase (ALP) and Cbfa1/La Jolla, California 92037
2 Genomic Institute of the Novartis Research Runx2 gene expression in C3H10T1/2 cells with an EC50
of 1 M [3]. It also induces osteogenesis in pre-osteo-Foundation
10675 John Jay Hopkins Drive blasts (MC3T3-E1), and when combined with BMP-4,
can trans-differentiate pre-adipocytes (3T3-L1) and my-San Diego, California 92121
oblasts (C2C12) into osteoblasts [3]. Figure 1 shows the
effects of purmorphamine on induction of the expres-
sion of osteogenesis markers in C3H10T1/2 cells.Summary
Several signaling pathways, including bone morpho-
genetic protein (BMP), Wnt, and Hedgehog signaling,Previously, a small molecule, purmorphamine, was
identified that selectively induces osteogenesis in mul- are known to be involved in osteoblast differentiation.
Bone morphogenetic proteins belong to the transform-tipotent mesenchymal progenitor cells. In order to gain
insights into the mechanism of action of purmorpha- ing growth factor- (TGF-) superfamily. BMP induces
osteogenesis by binding to its transmembrane recep-mine, high-density oligonucleotide microarrays were
used to profile gene expression in multipotent mesen- tors and activating Smad proteins, which translocate
into the nucleus and mediate the expression of down-chymal progenitor cells treated with either purmorpha-
mine or bone morphogenetic protein-4 (BMP-4). In con- stream target genes [4] that promote the differentiation
of osteoblasts and chondrocytes. When C3H10T1/2trast to BMP-4 treatment, purmorphamine activates
the Hedgehog (Hh) signaling pathway, resulting in the cells are treated with BMP, the majority of cells differen-
tiate into osteoblasts. However, a significant number ofup- and downregulation of its downstream target genes,
including Gli1 and Patched. Moreover, the known Hh cells also differentiate into adipocytes [5], indicating that
BMP-induced differentiation is not lineage specific. Insignaling antagonists, cyclopamine and forskolin, com-
pletely block the osteogenesis and Glimediated tran- addition to BMP, canonical Wnt/-catenin signaling is
also involved in osteogenesis. Several Wnt proteins, in-scription induced by purmorphamine. These results
demonstrate that purmorphamine is a small molecule cluding Wnt3a, induce expression of the osteoblast
marker, alkaline phosphatase (ALP) in C3H10T1/2 cellsagonist of Hedgehog signaling, and it may ultimately
be useful in the treatment of bone-related disease and [6]. Loss of function in the Wnt signaling coreceptor
LRP5 leads to osteoporosis, and a gain-of-function mu-neurodegenerative disease.
tation in this receptor results in a high bone mass pheno-
type in mice [7]. Hedgehog proteins, like Wnt proteins,Introduction
are important signaling molecules which play critical
roles in the control of pattern formation and cellularMesenchymal stem cells (MSC) are capable of differenti-
ating into a number of cell lineages, including bone, proliferation/differentiation [8]. In vitro, Sonic Hedgehog
(Shh) induces ALP expression [9, 10], and also increasescartilage, adipose, muscle, stroma, and tendon [1]. Among
them, bone is a highly specialized connective tissue selectivity in the differentiation of multipotent mesen-
chymal cells into the osteoblast lineage [11]. Thus, os-that undergoes constant remodeling by osteoblasts and
osteoclasts, which are responsible for bone formation teogenesis is a complex process that can likely be mod-
ulated by small molecules acting on a number ofand resorption, respectively. Misregulation of the differ-
signaling pathways.entiation of mesenchymal precursor cells into osteo-
High density oligonucleotide microarrays are a usefulblasts is involved in several bone-related diseases, in-
tool for analyzing the transcriptional effects of smallcluding osteoporosis, which affects an estimated 44
molecules [12, 13]. To gain insights into the cellular re-million Americans [2]. Identification of small molecules
sponse associated with purmorphamine treatment, wethat selectively induce osteoblast differentiation from
carried out transcriptional analysis of C3H10T1/2 cellsMSCs would provide useful chemical tools to study the
after treatment with purmorphamine and bone morpho-molecular mechanisms of osteoblast differentiation and
genetic protein 4 (BMP-4). Clustering analysis revealedultimately might lead to useful therapeutics agents for
that the gene expression pattern arising from purmor-the treatment of bone diseases.
phamine treatment differs significantly from that ofPreviously, by screening a combinatorial chemical li-
BMP-4 treatment. A cluster of genes was found to bebrary of more than 100,000 compounds, the small mole-
uniquely upregulated by purmorphamine treatment;cule purmorphamine was discovered, which can induce
pathway analysis of genes in this cluster revealed that
Hedgehog signaling is activated by purmorphamine*Correspondence: sding@scripps.edu (S.D.); schultz@scripps.edu
(P.G.S.) treatment. These results were confirmed by demonstra-
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Figure 1. Purmorphamine Induces Osteo-
genesis in Pluripotent Mesenchymal Progeni-
tor Cells
C3H10T1/2 cells were treated with 2 M of
purmorphamine (A and C) or 0.5% DMSO
control (B and D) for 4 days and stained for
alkaline phosphatase (A and B) and osteo-
pontin (Red, [C] and [D]). The chemical struc-
ture of purmorphamine is shown in (E).
ting that antagonists of Hedgehog signaling block the B2 (6-fold), Cyclin D1 (2.2-fold), Cyclin B1 (2.9-fold),
Cyclin A2 (3.5-fold), and CDK2 (2.3-fold). Genes respon-activity of purmorphamine.
sible for DNA synthesis, including ribonucleotide reduc-
tase M2 (3.7-fold) and M1 subunits (3.2-fold), were alsoResults and Discussion
upregulated. These data indicate that purmorphamine
treatment stimulates cellular proliferation at early stages,Transcriptional Analysis of Purmorphamine
and is consistent with our observation that purmorpha-and BMP-4 in Pluripotent Mesenchymal
mine-treated cells proliferate faster and have a higherProgenitor Cells
cell density after 2 days relative to control cells. OnceC3H10T1/2 cells were treated independently with 2 M
confluent, cells stop proliferating and differentiate intopurmorphamine, 100 ng/mL of BMP-4, and 1% DMSO
osteoblasts. We found that after 2 days of treatment(control) for either 12 hr, 24 hr, 2 days, 4 days, or 6 days.
with purmorphamine, multiple osteogenesis genes weremRNAs were isolated and biotinylated cRNAs were pre-
upregulated, including the essential osteogenesis tran-pared, fragmented, and subsequently hybridized to Af-
scription factor Cbfa1/Runx2 (2.0-fold); the core bindingfymetrix mouse genome U74Av2 GeneChips, which
protein  (Cbf-, 2.4-fold), a required cofactor for Cbfa1/represent all genes (6000) in the mouse UniGene Data-
Runx2-mediated skeletal development [14]; and otherbase that have been annotated, as well as 6000 ex-
osteoblast marker genes including alkaline phosphatasepressed sequence tag (EST) clusters. Each RNA sample
(3.6-fold) and osteomodulin (2.2-fold) [15]. Purmorpha-was hybridized onto duplicate sets of microarrays. For
mine treatment also abolishes spontaneous adipogenesiseach gene and EST, the difference in expression level
of C3H10T1/2 cells. Consistent with the observation, genesbetween purmorphamine, BMP-4-treated cells and con-
involved in adipogenesis, including apolipoprotein Etrol cells were calculated. Genes and ESTs with changes
(29-fold), adiponectin/Acrp30 (6.7-fold), lipoproteinin expression levels higher than 2-fold (up- or downregu-
lipase (3.4-fold) and adipose differentiation relatedlation) were analyzed.
protein (Adrp,3.1-fold) were downregulated after 24 hrOut of the 12000 genes and ESTs represented on
of purmorphamine treatment [16–19]. CCAAT/enhancerthe microarray, only a very small percentage of genes
binding protein- (CEBP-) and peroxisome prolifera-(0.5% to 2%) were differentially expressed. At early time
tor-activated receptor- (PPAR-), transcription factorspoints (24 hr), purmorphamine treatment led to the
upregulation of cell cycle control genes, including Cyclin involved in adipogenesis, were also downregulated 3-fold
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Figure 2. Clustering Analysis of Microarray data
Global clustering analysis of expression data after the treatment of DMSO (control), Purmorphamine, and BMP-4 (A) and 29 genes which are
upregulated uniquely by purmorphamine are displayed in a cluster (B).
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Table 1. List of 29 Genes which Are Upregulated by Purmorphamine Treatment as Identified from Clustering Analysis
Fold Change
Probe Set Gene/Description (at 4 Days)
94191_at Mus musculus protease-activated receptor 4 (Par4) mRNA, complete cds. 2.0
103520_at Mouse vascular endothelial growth factor mRNA, complete cds. 2.0
95627_at RIKEN cDNA 2310058J06 gene 2.0
160249_at Mus musculus D52 (mD52) mRNA, complete cds. 2.0
98497_at Mus musculus eps15R mRNA, complete cds. 2.2
100395_at M. musculus mRNA for gli2 gene 2.3
160527_at Mus musculus mRNA for mac25, complete cds. 2.3
92484_at Mus musculus mRNA for myc-intron-binding protein-1 2.9
101486_at M. musculus mRNA for proteasome subunit MECL-1 2.9
94504_at RIKEN cDNA 4930570C03 gene 3.3
104031_at Mus musculus patched mRNA, complete cds. 3.3
93451_at ESTs 3.3
103433_at pleckstrin homology, Sec7 and coiled-coil domains 3 3.8
103434_at Mus musculus guanine nucleotide exchange factor and integrin binding protein 3.8
homolog GRP1 mRNA, complete cds.
102780_at M. musculus (Balb/C) Tx01 mRNA 4.1
92426_at transmembrane 4 superfamily member 9 5.2
93321_at Mus musculus interferon-inducible protein 203 (Ifi203) mRNA, complete cds. 5.4
93007_at Mus musculus NPY-1 receptor 5.4
102849_at potassium inwardly-rectifying channel, subfamily J, member 8 5.6
95418_at RIKEN cDNA 1190017B18 gene 5.7
103362_at Mus musculus mRNA for prostaglandin E receptor EP2 subtype, complete cds. 5.8
96557_at Mus musculus ptch2 mRNA, complete cds. 5.9
97402_at Mus musculus thioether S-methyltransferase mRNA, complete cds. 6.0
92796_at Mouse placental alkaline phospatase mRNA, complete cds. 6.1
94097_at Mus musculus Gli1 mRNA, complete cds. 6.9
102906_at Mus musculus (clone U2) T-cell specific protein mRNA, complete cds. 9.4
104030_at RIKEN cDNA A230106A15 gene 17.7
95082_at insulin-like growth factor binding protein 3 89.9
95083_at M.musculus mRNA for insulin-like growth factor binding protein-3 100
and 2.2-fold, respectively. CEBP- is known to activate Clustering and Pathway Analysis Reveals
that Purmorphamine Activates the Hedgehogthe expression of CEBP- and PPAR-, which then tran-
Signaling Pathwayscriptionally activate genes that produce the adipocyte
The gene expression data suggests that purmorpha-phenotype [20].
mine has a distinct biological activity relative to BMP inBMP-4 treatment also induces cellular proliferation at
C3H10T1/2 cells. However, this analysis did not provideearly stages (24 hr), and like purmorphamine, causes
enough information to determine which signaling path-upregulation of genes involved in cell cycle control and
ways purmorphamine affects. Hierarchical clusteringDNA synthesis, including Cyclin B2 (5.8-fold), Cyclin A2
can be used to group genes with similar patterns of(5.1-fold), Cyclin B1 (3.6-fold), and the ribonucleotide
expression, and allows systematic analysis of the largereductase M2 (5.0-fold) and M1 subunits (5.7-fold). This
amounts of information obtained from genome-wide ex-suggests that initial cell number expansion might be
pression profiles [25, 26]. Therefore, those genes thatan important component of the differentiation process.
were induced or repressed by treatment with purmor-Several known target genes of BMP signaling, including
phamine across all time points were clustered by Z scoreinhibitor of DNA binding-1 (Id-1) (2.0-fold) and Id-3 (2.1-
with an agglomerative algorithm using the Rosetta Re-fold), were upregulated after 24 hr of treatment with
solver software (Figure 2A). Among the 12,000 genesBMP-4 [21]. In contrast, purmorphamine did not induce
and ESTs in the MG_U74Av2 array, only one cluster of
these genes’ expression, indicating that purmorphamine
29 genes was found to have low expression levels (low
does not activate BMP signaling, and suggesting that Z scores) under control conditions (DMSO treatment),
expression of Id genes may not be essential for os- and high expression levels (high Z scores) after treat-
teogenesis [22]. After treatment with BMP-4 for 4 days, ment with purmorphamine at all time points. The cluster-
several adipogenesis genes were upregulated, including ing diagram and list of the 29 genes in this cluster are
adipose differentiation related protein (Adrp, 3.8-fold), shown in Figure 2B and Table 1. No cluster of signifi-
apolipoprotein E (2.9-fold), fatty acid synthase (2.9-fold), cantly downregulated genes was found from this analy-
and PPAR (2.4-fold). These data are consistent with sis. Among the genes in the upregulated cluster, we
previous studies of expression analysis of BMP signal- found several transcription factors, including Gli2 (2.3-
ing in mesenchymal cells [22–24], and suggest that BMP fold), Gli1 (6.9-fold), and c-Myc intron binding protein-1
is not an osteogenesis-specific inducing factor—cells (2.8-fold) that are upregulated by treatment with purmor-
can differentiate into either osteoblasts or adipocytes phamine, but not by treatment with BMP-4. Similarly,
membrane-bound receptors and signal transductionwhen treated with BMPs.
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Figure 3. Purmorphamine Activates the
Hedgehog Signaling Pathway
Genes in the biological interaction network
related to Hedgehog signaling pathway as
displayed using the Ingenuity Pathway Analy-
sis software ([A], see http://www.ingenuity.
com for detailed explanations of the sym-
bols). Genes whose expression is increased
by purmorphamine are displayed by shaded
symbols. The expression levels of Gli1,
Patched (Ptc), Shh, Ihh, Dhh, and GAPDH at
different time points after the treatment of 2
M of purmorphamine () or DMSO control
() are determined by semiquantitative RT-
PCR (B).
molecules were also upregulated upon treatment with identified in previous microarray expression analysis ex-
periments as downstream targets of Hedgehog signal-purmorphamine but not BMP-4, including Patched 2
(5.9-fold), Patched (3.3-fold), and insulin like growth fac- ing [27–30]. Secreted frizzled-related protein-1 (Sfrp1)
and Sfrp-2 are known antagonists of Wnt signaling, andtor binding protein 3 (IGFBP-3, 90-fold).
To determine which biological pathways are affected are known to be strongly repressed by Hedgehog signal-
ing [28]. Consistent with this observation, treatment withby purmorphamine, the cluster of 29 upregulated genes
was subjected to Ingenuity Pathway Analysis (Ingenuity purmorphamine also strongly downregulates expres-
sion of Sfrp-1 (–3.2-fold) and Sfrp-2 (15.1-fold) (TableSystems). Hedgehog signaling pathway is the top scored
biological network, suggesting that the osteogenesis 2). Because Wnt signaling is also known to promote
osteogenesis, suppression of the expression of Wnt an-activity of purmorphamine might be associated with
modulation of this pathway (Figure 3A). Genes involved tagonists by purmorphamine may contribute to its os-
teogenesis activity. Taken together, the above analysisin Hedgehog signaling that are significantly induced by
purmorphamine treatment include Gli1 (6.9-fold), Gli2 suggested that purmorphamine may act as a small mole-
cule agonist of the Hedgehog signaling pathway.(2.3-fold), Patched (3.3-fold), Patched 2 (5.9-fold), and
IGF binding protein-3 (90-fold). These same genes were Hedgehog signaling plays an important role during
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Table 2. Expression Levels of Hedgehog Genes (Shh, Ihh, and Dhh) and Some Known Hedgehog Signaling Downstream Targets
Fold Change (P Value)
Probe Set Gene/Description 12 hr 24 hr 2 days 4 days 6 days
94097_at Mus musculus Gli1 mRNA, 2.1 (0.018) 2.7 (8.8E-13) 5.5 (1.6E-39) 6.9 (0) 6.9 (0)
100395_at GLI-Kruppel family member Absent (0.5) 1.2 (1) 1.1 (0.9) 2.3 (1.8E-5) 1.2 (0.034)
GLI2
104031_at Mus musculus patched 1.2 (0.7) 1.6 (0.08) 3.1 (1.6E-12) 3.3 (3E-17) 3.9 (1.4E-23)
mRNA
96557_at Mus musculus patch2 Absent (1) Absent (0.7) 2.7 (2.7E-6) 5.9 (2.6E-11) 9.4 (3.2E-22)
mRNA
95082_at insulin-like growth factor Absent (0.8) Absent (0.2) 20.1 (0) 89.9 (0) 86.9 (0)
binding protein 3
98623_g_at M. musculus gene for IGF-II, 1.1 (0.1) 1.2 (0.2) 1.2 (0.6) 4.1 (7.4E-14) 18.8 (1.8E-14)
exon 6.
93503_at Mus musculus secreted 14 (9.5E-13) 2.1 (0.01) 13.4 (1.5E-12) 15.2 (7.5E-11) 15.7 (4.5E-11)
frizzled related protein
sFRP-2 (Sfrp2) mRNA
97997_at Mus musculus secreted 6.5 (4.4E-4) 2.6 (0.037) 4.4 (0.0066) 2.8 (0.026) 2.8 (0.028)
frizzled related protein
sFRP-1 (Sfrp1) mRNA
101831_at M. musculus Shh mRNA 1.2 (0.51) 1.2 (0.58) 1.1 (0.67) 1.0 (0.92) 1.1 (0.66)
103949_at M. musculus Ihh mRNA 1.0 (0.96) 1.1 (0.86) 1.1 (0.69) 1.1 (0.72) 1.1 (0.82)
99861_at M. musculus Dhh gene 1.1 (0.47) 1 (0.98) 1.1 (0.69) 1.1 (0.69) 1.0 (0.8)
Fold changes and P values of differential expression compared with DMSO controls are shown. Positive values show upregulation and negative
values show downregulation.
the development of a wide range of tissues and organs, sion levels of Ptc and Gli1 were upregulated significantly
as early as 12 hr after treatment with purmorphamine,including lung, bone, CNS, limb, and hair follicles. In
vertebrates, the hedgehog family consists of three se- suggesting that activation of Hedgehog signaling is an
early and primary response to purmorphamine. The ex-creted proteins: Sonic Hedgehog (Shh), Indian Hedge-
hog (Ihh), and Desert Hedgehog (Dhh) [8]. Response to pression of Shh and Dhh is not detectable by RT-PCR.
Ihh is endogenously expressed, but its expression levelthe Hedgehog (Hh) signal is controlled by two transmem-
brane proteins, Patched (Ptc) and Smoothened (Smo). does not change throughout all time points of purmor-
phamine treatment, suggesting that the activation ofIn the resting state, Smo activity is suppressed by Ptc;
Hh stimulation releases the inhibitory effect of Ptc and Hedgehog signaling is not the result of the upregulation
of the expression of hedgehog proteins. These resultssubsequently activates Smo. Activated Smo then acti-
vates downstream signaling molecules, leading to the are consistent with our microarray data, which showed
that the P values of differential expression of all threeactivation of the Gli family of transcription factors, in-
cluding Gli1, Gli2, and Gli3. The transmembrane recep- Hedgehog genes are high. Therefore, the probability of
differential expression of these genes (compared withtor Ptc and the transcription factor Gli1 are also direct
downstream targets of Hedgehog signaling, leading to controls) is very low (Table 2). To further demonstrate
that purmorphamine activates Hedgehog signaling, aboth negative and positive feedback regulation [8].
Recently, members of the hedgehog gene family have Hedgehog signaling reporter assay was carried out. A
luciferase reporter plasmid containing multiple Gli bind-also been shown to regulate the development of verte-
brate skeleton [31–34]. Ihh was first identified as a regu- ing sites and a minimal promoter upstream of a firefly
luciferase gene was transfected into C3H10T1/2 cellslator of chondrocyte differentiation, and has also been
shown to play an important role in osteoblast differentia- [36–39]. As a positive control, addition of Sonic Hedge-
hog protein (expressed in E. coli, 1 g/mL) resulted intion [31]. Mice lacking Shh cannot form vertebrae and
display severe defects of distal limb skeletal elements a 2- to 3-fold increase in luciferase activity. Luciferase
reporter activity increased up to 6-fold when cells were[35]. Shh protein can also induce the expression of alka-
line phosphatase (ALP) in multipotent mesenchymal treated with 2 M of purmorphamine (Figure 4A). The
EC50 of purmorphamine in this assay is 0.5 M. Thesecells and pre-osteoblast cells and inhibit adipogenesis
in vitro [11]. Therefore, it is reasonable that the os- results are consistent with the notion that purmorpha-
mine acts as a small molecule agonist for Hedgehogteogenesis effects of purmorphamine result from the
activation of Hedgehog signaling. signaling [37, 39]. Furthermore, anti-Shh antibody (5E1)
cannot inhibit the Gli activity induced by purmorphamine
(Figure 4B), suggesting purmorphamine does not acti-Purmorphamine Is a Small Molecule Agonist
of Hedgehog Signaling vate Hedgehog signaling pathway by inducing the ex-
pression of Hedgehog protein.To confirm that purmorphamine activates expression of
genes in the Hedgehog signaling pathway, semiquanti- The effects of two well-known Hedgehog antagonists,
cyclopamine and forskolin, on the osteogenesis activitytative RT-PCR experiments were carried out on the
genes Patched (Ptc), Gli1, and all three Hedgehog genes of purmorphamine and BMP-4 were then examined.
Cyclopamine is a plant-derived, steroidal alkaloid which(Shh, Ihh, and Dhh). As shown in Figure 3B, the expres-
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Figure 4. Purmorphamine Could Activate
Hedgehog Signaling Independent of Hedge-
hog Ligand
Activation of Gli-mediated transcription by
purmorphamine (A) and anti-Shh antibody
(5E1) has no inhibitory effect on Gli activity
induced by 2 M of purmorphamine (Pur),
but inhibits the activity of recombinant Shh
protein (1 g/mL) (B).
blocks Hedgehog signaling by inhibiting the membrane naling by purmorphamine were confirmed with the
Hedgehog signaling reporter assay described above. Asprotein Smoothened [39–41]. Forskolin is an adenylate
cylase/protein kinase A (PKA) activator [42], which shown in Figure 5B, cyclopamine and forskolin can both
block the transcriptional activity of Gli induced by 2 Mblocks Hedgehog (Hh) signaling by stimulating the deg-
radation of members of the Gli family of transcriptional of purmorphamine, with IC50 values of 2.5 M and 5 M,
respectively. At concentrations higher than 10M, theseactivators [43]. It has been reported that forskolin has
synergistic effects on BMP-induced osteogenesis [44]. inhibitors completely block the transcriptional activity
of Gli. Cyclopamine blocks Hedgehog signaling at theAs shown in Figure 5A, after 4 days, ALP activity of
purmorphamine (2 M) treated cells is 70-fold higher level of Smoothened, suggesting that purmorphamine
activates either Smoothened or a protein upstream ofthan the control (0.5% DMSO-treated cells). The os-
teogenesis activity of purmorphamine (2M) is inhibited it in the Hedgehog signaling pathway.
by cyclopamine with an IC50 of 0.8 M, consistent with
the notion that purmorphamine activates Hedgehog sig- Significance
naling. At concentrations of cyclopamine greater than
10 M, osteogenesis is completely blocked. Forskolin Understanding the molecular mechanisms by which
small molecules affect cellular activity remains a chal-also has a very strong inhibitory effect on the osteo-
genesis activity of purmorphamine. Treatment with 100 lenge. Genome-wide expression analysis can provide
insights into which biological pathways are affectednM forskolin inhibits the ALP activity induced by purmor-
phamine (2 M) by more than 70%; at concentrations by small molecules. In this study, expression analysis
by microarrays suggested that purmorphamine actsgreater than 1 M, forskolin completely blocks ALP ex-
pression. By contrast, forskolin acts synergistically with as a Hedgehog signaling agonist. This was confirmed
in cellular reporter assays and by using known antago-BMPs10 M forskolin enhances ALP expression in-
duced by BMP by 5-fold [44]. This result further confirms nists of the Hedgehog signaling pathway. Because
Hedgehog signaling is known to play an importantthat purmorphamine induces osteogenesis primarily by
activating Hedgehog (Hh) signaling, and functions by a role in the development of many tissue and organs [8,
45–49], activation of this pathway may have therapeu-different mechanism than BMP. The effects of cyclop-
amine and forskolin on the activation of Hedgehog sig- tic value. Indeed, recent studies have demonstrated
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Figure 5. Hedgehog Antagonists Could In-
hibit Purmorphamine Function
Hedgehog (Hh) signaling antagonists, cyclo-
pamine and forskolin, inhibit osteogenesis (A)
and Gli-mediated transcription (B) induced by
2 M purmorphamine (Pur).
were performed in PBS (Gibco) with 0.3% Triton X-100 and 6%positive effects of Hedgehog proteins in the treatment
horse serum. Primary goat anti-osteopontin antibody was used atof Parkinson’s disease and peripheral nerve damage
a 1:250 dilution (Santa Cruz Biotechnologies). Secondary antibody[50, 51]. Therefore, small molecules which modulate
was Cy3-conjugated anti-goat antibody (Jackson ImmunoResearch,
Hedgehog signaling might be useful in the develop- 1:500). Cell nuclei were stained with DAPI (Roche). Images were
ment of new medicines for the treatment of diseases, recorded on a Nikon Eclipse TE300 microscope with 200 magnifi-
cation. Double- or triple-labeled images were assembled in Meta-such as osteoporosis and neurodegenerative disease
morph.[37, 39].
Total RNA Extraction, cDNA Preparation,Experimental Procedures
and GeneChip Hybridization
Total RNA from different samples was isolated and purified with theCell Culture
RNeasy Mini Kit (Qiagen, Valencia, CA). Double-stranded cDNA wasMouse embryonic mesoderm fibroblasts C3H10T1/2 cells (obtained
synthesized from 5 g of total RNA with the SuperScript Choicefrom American Type Culture Collection, ATCC, Manassas, VA) were
System (Invitrogen, Carlsbad, CA) and T7-(dT)24 primer (Geneset, Lacultured in MEM-medium (Gibco/Invitrogen, Carlsbad, CA) supple-
Jolla, CA). In vitro transcription was carried out with an Ambionmented with 10% heat-inactivated FBS (Gibco/Invitrogen, Carlsbad,
in vitro transcription kit using double-stranded cDNA as the templateCA), 50 units/mL penicillin and 50 g/mL of streptomycin (Gibco/
in the presence of biotinylated UTP and CTP. Biotin-labeled cRNAInvitrogen, Carlsbad, CA) at 37C with 5% CO2 in air atmosphere.
was purified, fragmented, and hybridized to Murine genome U74Av2To induce differentiation, cells were plated in 10 cm dishes at a
arrays (Affymetrix Incorporated, Santa Clara, CA) according to thedensity of 106 cells in 10 ml of culture medium (80% confluence).
protocol suggested by the manufacturer. Chips were scanned, andAfter 12 hr, 2 M of purmorphamine (dissolved in DMSO to make
the hybridization data were acquired using Affymetrix Suite 5.0.10 mM solution) and 100 ng/mL of BMP-4 or 0.02% DMSO was
Each RNA sample was hybridized onto duplicate sets of microarraysadded into culture media.
to minimize experimental error.
Histochemical and Immunofluorescent Staining
Cells were fixed with 10% formalin solution (Sigma) for 15 min in Microarray Data Analysis
To find transcripts differentially expressed between purmorphamine96-well plate. Fixed cells were washed with PBS (200 L, 3 times)
and stained with the Alkaline Phosphatase Staining Kit 86R (Sigma and control conditions, samples across all time points were clus-
tered by Z score with an agglomerative algorithm using the RosettaDiagnostics) following the manufacturer’s protocol. Immunostains
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